European Commission urged to expand clinical trials initiative focusing on Africa
This article was originally published in Scrip
Executive Summary
The European Commission is being urged to expand the scope of an EU research and development programme that was set up to accelerate the development of new drugs against HIV/AIDS, malaria and tuberculosis and that focuses on conducting clinical trials in Sub-Saharan Africa.